Tianyin Pharmaceutical Co., Inc. - TPI

Tianyin Pharmaceutical Co., Inc. (TPI)
http://www.tianyinpharma.com
Coverage: October 3, 2009 - October 3, 2010
Featured: October 3, 2009

Latest Newsletter Editions

spacer
Sat, May 22, 2010 @ 02:05 pm
There was a little relief rally on Friday after a fairly wicked week in the markets. Thursday's giant sell down felt like a "cash at any cost" down draft, with almost no regard for value. That's fine with me. These kinds of emotional, momentum driven markets present opportunities for those with the...
Tue, May 18, 2010 @ 10:05 am
A Busy Day- Comments on a Bunch of Stuff Frankly, it's a bit annoying. I wish these smaller companies could get their quarterly numbers out over a few week period in time, instead of all in one or two days at the absolute deadline. I just can't get quality commentary out fast enough for investors to...
Mon, Feb 1, 2010 @ 03:02 pm
Nothing Like a Cool $200 Million You might wonder who's got the cool $200 million, and what it has to do with today's edition of the OTC Journal. Remember my short term trading idea?- TapImmune (OTC BB: TPIV) I said some positive developments would start to roll their way, and today's post close news...
Wed, Jan 27, 2010 @ 09:01 am
Two Beat Downs; Stand By I just wanted to publish a couple of quick notes on two stocks I've been covering and have made comments on recently. First on China Recycling Energy (CREG)- someone is selling the stock fairly ruthlessly with little regard for price. It started two days ago, and the stock is...
Thu, Jan 21, 2010 @ 01:01 pm
How The Immune System Fights Disease Our bodies have a miraculous capability. Our Immune System, through a complex network of cells and chemicals, has the ability to identify bad stuff and rapidly recruit an army to attack foreign invaders and kill them. T-Cells are the circus ring masters. The T-Cells...

Click Here For More Newsletters on TPI

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 0.64 Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: 10:32am Bid x Ask Size: N/A
Change: up arrow +0.0100 (+1.59%) Day's Range: 0.62 - 0.65
Prev Close: 0.6300 52wk Range: 0.58 - 1.44
Open: 0.6300 P/E (ttm): 3.50
Volume: 4,670 EPS (ttm): 0.18
spacer [Chart]

Business Summary

spacer
Tianyin Pharmaceutical Co., Inc. engages in the development, manufacture, marketing, and sale of modernized traditional Chinese medicines and other pharmaceuticals in the People’s Republic of China. The company’s products are intended to address various medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology, and pediatrics. It manufactures a portfolio of 39 modernized traditional Chinese medicines and pharmaceuticals, and has a pipeline of 17 products, which are pending regulatory approvals with the China State Food and Drug Administration. The company was founded in 1994 and is based in Chengdu, the People’s Republic of China.

Disclosure

spacer
The OTC Journal has received no compensation for coverage of Tianyin Pharmaceutical Co., Inc.

Recent News Headlines

spacer
Qionglai Facility (QLF) Schedules September for GMP Examination
Mon, 18 Aug 2014 12:30:00 GMT
[PR Newswire] - CHENGDU, China, Aug. 18, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates for the GMP certification regarding the Company's Qionglai Facility (QLF). Through a series of testing runs using various traditional Chinese medicine (TCM) raw materials at individual production lines, QLF has been preparing for the final GMP examination by the provincial China Food and Drug Administration (CFDA).
Testing Runs Progress Updates for TPI's Qionglai Facility
Mon, 04 Aug 2014 07:11:00 GMT
[PR Newswire] - CHENGDU, China, Aug. 4, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
TPI Targets Early August 2014 to Start Qionglai Facility (QLF) GMP Inspection
Mon, 14 Jul 2014 13:51:00 GMT
[PR Newswire] - CHENGDU,China, July 14, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided updates regarding the Company's Qionglai Facility (QLF). QLF, after the completion of its construction followed by the equipment installation, has conducted a series of procedures and tests that prepare the facility for GMP certification by the China Food & Drug Administration (CFDA).
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events
Tue, 08 Jul 2014 10:06:52 GMT
TPI Receives GMP for Tablets Formulation in Early July
Mon, 07 Jul 2014 12:53:00 GMT
[PR Newswire] - CHENGDU, China, July 7, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TPI Attends CPhI to Facilitate Azithromycin API Export Business
Mon, 30 Jun 2014 00:08:00 GMT
[PR Newswire] - CHENGDU, China, June 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events
Mon, 23 Jun 2014 12:58:54 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Wed, 28 May 2014 21:12:27 GMT
TIANYIN PHARMACEUTICAL CO., INC. Financials
Fri, 23 May 2014 17:04:24 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mon, 19 May 2014 20:50:32 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 10-Q, Quarterly Report
Thu, 15 May 2014 20:11:07 GMT
Tianyin Pharmaceutical's (TPI) F3Q 2014 Results - Earnings Call Transcript
Thu, 15 May 2014 16:30:09 GMT
[at Seeking Alpha] - Operating income was $0.4 million, compared with $1.8 million in third quarter fiscal year 2013. Operating income was $5 million for the nine months ended March 31, 2014 as compared to $6.5 million for ...
TPI Reports Third Quarter Fiscal Year 2014 Financial Results
Thu, 15 May 2014 12:53:00 GMT
[PR Newswire] - CHENGDU, China, May 15, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events
Wed, 14 May 2014 10:04:27 GMT
TPI Provides Updates on Annual Meeting
Mon, 12 May 2014 03:28:00 GMT
[PR Newswire] - CHENGDU, China, May 11, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional ...
TPI to Host Third Quarter Fiscal Year 2014 Earnings Conference Call on Thursday, May 15, 2014 at 9:00 a.m. ET
Fri, 09 May 2014 01:17:00 GMT
[PR Newswire] - CHENGDU, China, May 8, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Tue, 06 May 2014 15:42:06 GMT
TPI Presented at Guosen Securities Investment Conference at Shenzhen, China
Thu, 24 Apr 2014 12:00:00 GMT
[PR Newswire] - CHENGDU, China, April 24, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sales of patented biopharmaceutical medicine, ...
JCM Updates on Azithromycin API Export
Thu, 17 Apr 2014 01:29:00 GMT
[PR Newswire] - CHENGDU, China, April 16, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events
Mon, 07 Apr 2014 18:37:49 GMT